Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Hematology
Published in: BMC Hematology 1/2016

Open Access 01-12-2016 | Study protocol

A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol

Authors: Marlous J. Madderom, Jessica Heijdra, Elisabeth M. W. J. Utens, Suzanne Polinder, Anita W. Rijneveld, Marjon H. Cnossen

Published in: BMC Hematology | Issue 1/2016

Login to get access

Abstract

Background

Sickle cell disease (SCD) is endemic in non-Western countries. Due to migration, the prevalence of SCD in the Netherlands has increased. Adherence to medical treatment is recognized as a major problem area. Therefore, new effective interventions to increase adherence are urgently needed.

Methods/design

The TEAM study is an ongoing randomized controlled trial (RCT) to compare protocolized individual medical appointments (IMA’s; care-as-usual) with protocolized group medical appointments (GMA’s; novel intervention) in pediatric (n = 40) and adult (n = 60) patients. The study aims to assess the effectiveness of GMA’s (over a three year period) on patients’ self-efficacy, adherence, quality of life, morbidity, hospital admissions and satisfaction with the treating professional; as well as to test the cost-effectiveness of GMA’s. In both the IMA and GMA groups structured assessments will be performed at baseline (start of the study), after 1.5 and after 3 years.

Discussion

This is the first RCT to investigate the effectiveness of GMA’s on self-efficacy and adherence in pediatric and adult patients with SCD, including a cost-effectiveness analysis.

Trial registration

NTR4750 (NL42182.000.12). Registered 13 August 2014.
Literature
1.
Fox P, Ingram D. Theory and practice of self-induced pain management: approaches learned from effective copers. J Black Psychol. 1999;25:427–52.CrossRef
2.
Peters M, Appel IM, Cnossen MH, Breuning-Boers JM, Heijboer H. Sikkelcelziekte in de hielprikscreening. Ned Tijdschr Geneeskd. 2009;153:359.
3.
Peters M, Fijnvandraat K, Van Den Tweel XW, Garre FG, Giordano PC, Van Wouwe JP, Pereira RR, Verkerk PH. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening. Arch Dis Child. 2010;95:822–5.CrossRefPubMed
4.
Ballas SK. Self-management of sickle cell disease: a new frontier. J Nati Med Assoc. 2010;102:1042.CrossRef
5.
van Tuijn CFJ, van Beers EJ, Schnog JJB, Biemond BJ. Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease. Am J Hematol. 2010;85:532–5.CrossRefPubMed
6.
Clay OJ, Telfair J. Evaluation of a disease-specific self-efficacy instrument in adolescents with sickle cell disease and its relationship to adjustment. Child Neuropsychol. 2007;13:188–203.CrossRefPubMed
7.
Edwards R, Telfair J, Cecil H, Lenoci J. Reliability and validity of a self-efficacy instrument specific to sickle cell disease. Behav Res Ther. 2000;38:951–63.CrossRefPubMed
8.
Edwards R, Telfair J, Cecil H, Lenoci J. Self-efficacy as a predictor of adult adjustment to sickle cell disease: One-year outcomes. Psychosom Med. 2001;63:850–8.CrossRefPubMed
9.
Schmucker D. Group medical appointments: An introduction for health professionals: Jones and Bartlett Publishers. 2006.
10.
Zantinge EM, Seesing FM, Tol FE, Raats CJI, Spreeuwenberg PMM, van Dulmen AMS. Gezamenlijk Medisch Consult: samen naar de dokter. Ervaringen van patienten en zorgverleners. Ned Tijdschr Geneeskd. 2009;153:A828.PubMed
11.
Jaber R, Braksmajer A, Trilling J. Group visits for chronic illness care: models, benefits and challenges. Fam Pract Manag. 2006;13:37.PubMed
12.
Jaber R, Braksmajer A, Trilling JS. Group visits: a qualitative review of current research. J Am Board Fam Med. 2006;19:276–90.CrossRefPubMed
13.
Marks R, Allegrante JP, Lorig K. A. review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (Part I). Health Promot Pract. 2005;6:37–43.CrossRefPubMed
14.
Scott JC, Conner DA, Venohr I, Gade G, McKenzie M, Kramer AM, Bryant L, Beck A. Effectiveness of a group outpatient visit model for chronically ill older health maintenance organization members: a 2‐year randomized trial of the cooperative health care clinic. J Am Geriatr Soc. 2004;52:1463–70.CrossRefPubMed
15.
Shojania K, Ratzlaff M. Group visits for rheumatoid arthritis patients: a pilot study. Clin Rheumatol. 2010;29:625–8.CrossRefPubMed
16.
Thacker HL, Maxwell R, Saporito J, Bronson D. Shared medical appointments: facilitating interdisciplinary care for midlife women. J Womens Health. 2005;14:867–70.CrossRef
17.
Bartley KB, Haney R. Shared medical appointments: improving access, outcomes, and satisfaction for patients with chronic cardiac diseases. J Cardiovasc Nurs. 2010;25:13–9.CrossRefPubMed
18.
Edelman D, Fredrickson SK, Melnyk SD, Coffman CJ, Jeffreys AS, Datta S, Jackson GL, Harris AC, Hamilton NS, Stewart H. Medical clinics versus usual care for patients with both diabetes and hypertension a randomized trial. Ann Intern Med. 2010;152(11):689–96.CrossRefPubMed
19.
Fletcher SG, Clark SJ, Overstreet DL, Steers WD. An improved approach to followup care for the urological patient: drop-in group medical appointments. Journal Urol. 2006;176:1122–6.CrossRef
20.
Maizels M, Saenz V, Wirjo J. Impact of a group‐based model of disease management for headache. Headache. 2003;43:621–7.CrossRefPubMed
21.
Riley SB, Marshall ES. Group visits in diabetes care a systematic review. Diabetes Educ. 2010;36:936–44.CrossRefPubMed
22.
Lock J, De Bruin A, Scholten M, Joosten M, Seesing FM, Beishuizen A, De Goede‐Bolder A, Cnossen MH. The group medical appointment (GMA) in haemophilia and von Willebrand’s disease: a new development in outpatient paediatric care. Haemophilia. 2012;18:766–72.CrossRefPubMed
23.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.CrossRefPubMed
24.
Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–67.CrossRefPubMed
25.
Varni JW, Seid M, Kurtin PS. PedsQL™ 4.0: reliability and validity of the pediatric quality of life inventory™ version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800–12.CrossRefPubMed
26.
Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160.CrossRefPubMedPubMedCentral
27.
Bessette L, Sangha O, Kuntz KM, Keller RB, Lew RA, Fossel AH, Katz JN. Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome. Med Care. 1998;36:491–502.CrossRefPubMed
28.
Sloan JA, Loprinzi CL, Kuross SA, Miser AW, O’Fallon JR, Mahoney MR, Heid IM, Bretscher ME, Vaught NL. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998;16:3662–73.CrossRefPubMed
29.
Tan SS, Bouwmans-Frijters AM, Hakkaart-van Roijen LH. Handleiding voor kostenonderzoek: Methoden en referentie prijzen voor economische evaluaties in de gezondheidszorg. Tijdschrift voor gezondheidswetenschappen. 2012;90:367–72.CrossRef
30.
Tan SS, Bouwmans CAM, Rutten FFH, Hakkaart-van Roijen L. Update of the Dutch manual for costing in economic evaluations. Int J Technol Assess Health Care. 2012;28:152–8.CrossRefPubMed
31.
32.
Morley S, Eccleston C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain. 1999;80:1–13.CrossRefPubMed
33.
Cohen J. Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Inc; 1977.
Metadata
Title
A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol
Authors
Marlous J. Madderom
Jessica Heijdra
Elisabeth M. W. J. Utens
Suzanne Polinder
Anita W. Rijneveld
Marjon H. Cnossen
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Hematology / Issue 1/2016
Electronic ISSN: 2052-1839
DOI
https://doi.org/10.1186/s12878-016-0058-4

Other articles of this Issue 1/2016

BMC Hematology 1/2016 Go to the issue

Study protocol

Anticoagulated patient’s perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy – study protocol for The Switching Study: a prospective cohort study

Research article

Anaemia and its association with month and blood phenotype in blood donors in Fako division, Cameroon

Research article

KIR repertory in patients with hematopoietic diseases and healthy family members

Research article

Prevalence of neutropenia in children by nationality

Debate

Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process

Research article

Generic and disease-specific quality of life among youth and young men with Hemophilia in Canada
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits